-
GEMMABio Announces Duchenne Muscular Dystrophy Program, Shares Preclinical Data for Investigational Gene Therapy for Duchenne
Today, Gemma Biotherapeutics (GEMMABio), a clinical‑stage, global, genetic therapeutics company, shared information about the company’s
-
MDA Ambassador Guest Blog: Embers of Resilience Through Depression
Joshua Vinson enjoys rain, camping, and cooking. Joshua works as a Quality Assurance Specialist in
-
When it comes to accessibility, even the best-laid plans can go awry
On May 1, my daughter Jill graduated from the University of Pittsburgh with a master’s
-
Clinical Research Alert: Natural History Study in Individuals with Myotonic Dystrophy Type 2
Researchers at the University of Rochester are seeking adults with myotonic dystrophy type 2 (DM2) for
-
Exercise in Dystrophinopathy: What Families Need to Know
PPMD recently hosted a webinar centered on common questions from families: is exercise recommended in
-
This simple strength test could predict how long you live
Staying strong may be one of the biggest secrets to living longer — especially for
-
‘Heart-on-a-chip’ project to help researchers study BMD, DMD
Duchenne Parent Project Spain is investing €247,000 (just over $290,000 USD) in a project that
-
What MDA Summer Camp taught me about why we show up
This article was provided by our partner, the Muscular Dystrophy Association. It has been reviewed by
-
Remembering a dear friend, who taught me about leaving a legacy
My dear friend Colin Rensch had a saying: “If you think you can, then of
-
Guest Voice: After diagnosis, focusing on what we can do
It started long before I had the words to explain it. At 9 years old,
